Skip Navigation



JAC Advance Access published online on June 5, 2007

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm172
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/1/68    most recent
dkm172v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Artemenko, A. G.
Right arrow Articles by Schmidtke, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Artemenko, A. G.
Right arrow Articles by Schmidtke, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds

A. G. Artemenko1, E. N. Muratov1, V. E. Kuz'min1, N. A. Kovdienko1, A. I. Hromov1, V. A. Makarov2, O. B. Riabova2, P. Wutzler3 and M. Schmidtke3,*

1 A.V. Bogatsky Physical-Chemical Institute, Lustdorfskaya doroga 86, Odessa, Ukraine 2 Research Center for Antibiotics, Nagatinskaya Str. 3a, Moscow, Russia 3 Institute of Virology and Antiviral Therapy, Friedrich Schiller University, Hans-Knoell-Str. 2, Jena, Germany

Received 30 January 2007; returned 6 April 2007; revised 20 April 2007; accepted 23 April 2007


* Corresponding author. Tel: +49-3641-657222; Fax: +49-3641-657301; E-mail: michaela.schmidtke{at}med.uni-jena.de

Objectives: The objectives of this study were (i) to apply computer-based technologies to evaluate the structure of 48 N,N'-(bis-5-nitropyrimidyl)dispirotripiperazines which belong to a new class of highly active antiviral compounds binding to cell surface heparan sulphates, (ii) to understand the chemical–biological interactions governing their activities, and (iii) to design new compounds with strong antiviral activity.

Methods: The logarithm of 50% cytotoxic concentration (CC50) in GMK cells, of 50% inhibitory concentration (IC50) against herpes simplex virus type 1, and of selectivity index (SI = CC50/IC50) was used to develop quantitative structure–activity relationships (QSARs) based on simplex representation of molecular structure. The QSAR model was applied to design new compounds. Two of these compounds were synthesized, physico-chemically characterized and tested for cytotoxicity and antiviral activity.

Results: Statistic characteristics for partial least squares models allow the prediction of CC50, IC50 and SI values. The QSAR results demonstrate a high impact of individual structural fragments for antiviral activity. Molecular fragments that promote and interfere with antiviral activity were defined on the basis of the obtained models. Electrostatic factors (38%) and hydrophobicity (34%) were the most important determinants of antiherpetic activity. Using the established method, new potential dispirotripiperazine derivatives were computationally designed. Two of these computationally designed compounds were synthesized. The biological test results confirm the computationally predicted values of these compounds.

Conclusions: The established QSAR model is suitable for the design of new antiherpetic compounds and prediction of their activity.

Key Words: QSAR , SiRMS , herpes virus , heparan sulfate , antiviral , drug design


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.